Page 1855 - Hematology_ Basic Principles and Practice ( PDFDrive )

1649.e2 Part X Transplantation

42. Verneris MR, Brunstein CG, Barker J, et al: Relapse risk after umbilical 63. Barker JN, Byam C, Scaradavou A: How I treat: the selection and
cord blood transplantation: enhanced graft-versus-leukemia effect in acquisition of unrelated cord blood grafts. Blood 117(8):2332–2339,
recipients of 2 units. Blood 114(19):4293–4299, 2009. 2011.
43. Ruggeri A, de Latour RP, Rocha V, et al: Double cord blood transplan- 64. Mitchell R, Wagner JE, Brunstein CG, et al: Impact of long-term cryo-
tation in patients with high risk bone marrow failure syndromes. Br J preservation on single umbilical cord blood transplantation outcomes.
Haematol 143(3):404–408, 2008. Biol Blood Marrow Transplant 21(1):50–54, 2015.
44. Milano F, Heimfeld S, Gooley T, et al: Correlation of infused 65. van Rood JJ, Stevens CE, Smits J, et al: Reexposure of cord blood to
CD3+CD8+ cells with single-donor dominance after double-unit cord noninherited maternal HLA antigens improves transplant outcome in
blood transplantation. Biol Blood Marrow Transplant 19(1):156–160, hematological malignancies. Proc Natl Acad Sci USA 106(47):19952–
2013. 19957, 2009.
45. Kang HJ, Yoo KH, Lee JW, et al: Double umbilical cord blood transplan- 66. Stevens CE, Carrier C, Carpenter C, et al: HLA mismatch direction in
tation for children and adolescents. Ann Hematol 89(10):1035–1044, cord blood transplantation: impact on outcome and implications for
2010. cord blood unit selection. Blood 118(14):3969–3978, 2011.
46. Kanda J, Rizzieri DA, Gasparetto C, et al: Adult dual umbilical cord 67. van Rood JJ, Scaradavou A, Stevens CE: Indirect evidence that maternal
blood transplantation using myeloablative total body irradiation microchimerism in cord blood mediates a graft-versus-leukemia effect in
(1350 cGy) and fludarabine conditioning. Biol Blood Marrow Trans- cord blood transplantation. Proc Natl Acad Sci USA 109(7):2509–2514,
plant 17(6):867–874, 2011. 2012.
47. Haspel RL, Kao G, Yeap BY, et al: Preinfusion variables predict the 68. McCullough J, McKenna D, Kadidlo D, et al: Mislabeled units of
predominant unit in the setting of reduced-intensity double cord blood umbilical cord blood detected by a quality assurance program at the
transplantation. Bone Marrow Transplant 41(6):523–529, 2008. transplantation center. Blood 114(8):1684–1688, 2009.
48. Gertow J, Berglund S, Okas M, et al: Characterization of long-term 69. McCullough J, McKenna D, Kadidlo D, et al: Issues in the quality
mixed donor-donor chimerism after double cord blood transplantation. of umbilical cord blood stem cells for transplantation. Transfusion
Clin Exp Immunol 162(1):146–155, 2010. 45(6):832–841, 2005.
49. Berglund S, Okas M, Gertow J, et al: Stable mixed donor-donor 70. Ponce DM, Lubin M, Gonzales AM, et al: The use of back-up units to
chimerism after double cord blood transplantation. Int J Hematol enhance the safety of unrelated donor cord blood transplantation. Biol
90(4):526–531, 2009. Blood Marrow Transplant 18(4):648–651, 2012.
50. Hashem H, Lazarus HM: Double umbilical cord blood transplanta- 71. Cutler C, Kim HT, Sun L, et al: Donor-specific anti-HLA antibodies
tion: relevance of persistent mixed-unit chimerism. Biol Blood Marrow predict outcome in double umbilical cord blood transplantation. Blood
Transplant 2014. 118(25):6691–6697, 2011.
51. Eldjerou LK, Chaudhury S, Baisre-de Leon A, et al: An in vivo model 72. Ruggeri A, Rocha V, Masson E, et al: Impact of donor-specific anti-
of double-unit cord blood transplantation that correlates with clinical HLA antibodies on graft failure and survival after reduced intensity
engraftment. Blood 116(19):3999–4006, 2010. conditioning-unrelated cord blood transplantation: a Eurocord, Societe
52. Brunstein CG, Noreen H, DeFor TE, et al: Anti-HLA antibodies Francophone d’Histocompatibilite et d’Immunogenetique (SFHI) and
in double umbilical cord blood transplantation. Biol Blood Marrow Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-
Transplant 17(11):1704–1708, 2011. TC) analysis. Haematologica 98(7):1154–1160, 2013.
53. Scaradavou A, Smith KM, Hawke R, et al: Cord blood units with low 73. Dahi PB, Barone J, Devlin SM, et al: Sustained donor engraftment in
CD34+ cell viability have a low probability of engraftment after double recipients of double-unit cord blood transplantation is possible despite
unit transplantation. Biol Blood Marrow Transplant 16(4):500–508, donor-specific human leukocyte antigen antibodies. Biol Blood Marrow
2010. Transplant 20(5):735–739, 2014.
54. Kim DW, Chung YJ, Kim TG, et al: Cotransplantation of third-party 74. Gutman JA, McKinney SK, Pereira S, et al: Prospective monitoring for
mesenchymal stromal cells can alleviate single-donor predominance alloimmunization in cord blood transplantation: “virtual crossmatch”
and increase engraftment from double cord transplantation. Blood can be used to demonstrate donor-directed antibodies. Transplantation
103(5):1941–1948, 2004. 87(3):415–418, 2009.
55. Yahata T, Ando K, Miyatake H, et al: Competitive repopulation assay 75. Kindwall-Keller TL, Hegerfeldt Y, Meyerson HJ, et al: Prospective
of two gene-marked cord blood units in NOD/SCID/gammac(null) study of one- vs two-unit umbilical cord blood transplantation fol-
mice. Mol Ther 10(5):882–891, 2004. lowing reduced intensity conditioning in adults with hematological
56. Delaney C, Heimfeld S, Brashem-Stein C, et al: Notch-mediated malignancies. Bone Marrow Transplant 47(7):924–933, 2012.
expansion of human cord blood progenitor cells capable of rapid 76. Scaradavou A, Brunstein CG, Eapen M, et al: Double unit grafts suc-
myeloid reconstitution. Nat Med 16(2):232–236, 2010. cessfully extend the application of umbilical cord blood transplantation
57. Gutman JA, Turtle CJ, Manley TJ, et al: Single-unit dominance after in adults with acute leukemia. Blood 121(5):752–758, 2013.
double-unit umbilical cord blood transplantation coincides with a 77. Wagner JE, Jr, Eapen M, Carter S, et al: One-unit versus two-unit
specific CD8+ T-cell response against the nonengrafted unit. Blood cord-blood transplantation for hematologic cancers. N Engl J Med
115(4):757–765, 2010. 371(18):1685–1694, 2014.
58. Brunstein CG, Miller JS, Cao Q, et al: Infusion of ex vivo expanded T 78. Ponce DM, Zheng J, Gonzales AM, et al: Reduced late mortality risk
regulatory cells in adults transplanted with umbilical cord blood: safety contributes to similar survival after double-unit cord blood transplanta-
profile and detection kinetics. Blood 117(3):1061–1070, 2011. tion compared with related and unrelated donor hematopoietic stem
59. Georges GE, Lesnikov V, Baran SW, et al: A preclinical model of cell transplantation. Biol Blood Marrow Transplant 17(9):1316–1326,
double- versus single-unit unrelated cord blood transplantation. Biol 2011.
Blood Marrow Transplant 16(8):1090–1098, 2010. 79. Wallet HL, Sobh M, Morisset S, et al: Double umbilical cord
60. Purtill D, Smith K, Devlin S, et al: Dominant unit CD34+ cell dose blood transplantation for hematological malignancies: a long-term
predicts engraftment after double-unit cord blood transplantation and analysis from the SFGM-TC registry. Exp Hematol 41(11):924–933,
is influenced by bank practice. Blood 124(19):2905–2912, 2014. 2013.
61. Barker JN, Byam CE, Kernan NA, et al: Availability of cord blood 80. Holtan SG, DeFor TE, Lazaryan A, et al: Composite end point of
extends allogeneic hematopoietic stem cell transplant access to racial and graft-versus-host disease-free, relapse-free survival after allogeneic
ethnic minorities. Biol Blood Marrow Transplant 16(11):1541–1548, hematopoietic cell transplantation. Blood 125(8):1333–1338, 2015.
2010. 81. Ruggeri A, Sanz G, Bittencourt H, et al: Comparison of outcomes
62. Tarek N, Gallagher MM, Chou JF, et al: KIR-HLA Genotypes Have No after single or double cord blood transplantation in adults with acute
Identifiable Role in Unit Predominance Following Double Unit Cord leukemia using different types of myeloablative conditioning regimen,
Blood Transplantation. Biol Blood Marrow Transplant 17(2):S286–S287, a retrospective study on behalf of Eurocord and the Acute Leukemia
2011. Working Party of EBMT. Leukemia 28(4):779–786, 2014.